Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

News Daily News ACC 2020

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Michael O'Riordan

March 23, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.